Unique ID issued by UMIN | UMIN000001992 |
---|---|
Receipt number | R000002429 |
Scientific Title | Effects of risedronate and alfacalcidol on parameters of atherosclerosis in type 2 diabetes patients with osteoporosis |
Date of disclosure of the study information | 2009/05/21 |
Last modified on | 2009/06/21 14:58:13 |
Effects of risedronate and alfacalcidol on parameters of atherosclerosis in type 2 diabetes patients with osteoporosis
Effects of risedronate and alfacalcidol on parameters of atherosclerosis
Effects of risedronate and alfacalcidol on parameters of atherosclerosis in type 2 diabetes patients with osteoporosis
Effects of risedronate and alfacalcidol on parameters of atherosclerosis
Japan |
Type 2 diabetes with osteoporosis
Endocrinology and Metabolism |
Others
NO
To investigate the effects of treatment with risedronate and alfacalcidol on parameters of atherosclerosis in Japanese postmenopausal women with type 2 diabetes associated with osteoporosis
Efficacy
Plaque score and abdominal aortic calcification score
Interventional
Parallel
Non-randomized
Open -but assessor(s) are blinded
No treatment
2
Treatment
Medicine |
Treatment with risedronate and alfacalcidol
No treatment
50 | years-old | <= |
Not applicable |
Female
Postmenopausal women with newly diagnosed osteoporosis, who visited our out clinic for education, evaluation, or treatment of type 2 diabetes, were enrolled if informed consent was obtained after a detailed explanation of the study purpose and methods.
Nobody had hepatic or renal dysfunction or nutritional derangements. All patients were free of drugs known to influence bone and calcium metabolism, such as vitamin D, bisphosphonate, or estrogen, up until the time of the study.
40
1st name | |
Middle name | |
Last name | Ippei Kanazawa |
Shimane University School of Medicine
Internal Medicine 1
89-1 Enya-cho, Izumo, Shimane
1st name | |
Middle name | |
Last name |
Shimane University School of Medicine
Internal Medicine 1
ippei.k@med.shimane-u.ac.jp
Department of Internal Medicine 1, Shimane University School of Medicine
Department of Internal Medicine 1, Shimane University School of Medicine
Self funding
NO
2009 | Year | 05 | Month | 21 | Day |
Unpublished
After 1 year treatment with risedronate and alfacalcidol, plaque score and abdominal aortic calcification score in the osteoporosis group were not statistically changed, while both two parameters in the control group were significantly increased
Completed
2008 | Year | 04 | Month | 01 | Day |
2008 | Year | 04 | Month | 01 | Day |
2009 | Year | 06 | Month | 01 | Day |
2009 | Year | 06 | Month | 01 | Day |
2009 | Year | 06 | Month | 01 | Day |
2009 | Year | 06 | Month | 01 | Day |
2009 | Year | 05 | Month | 21 | Day |
2009 | Year | 06 | Month | 21 | Day |
Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000002429
Research Plan | |
---|---|
Registered date | File name |
Research case data specifications | |
---|---|
Registered date | File name |
Research case data | |
---|---|
Registered date | File name |